Published in Cancer Weekly, October 16th, 1995
RGG0853 consists of DC-Cholesterol, RGene's lipid-based gene delivery system, complexed with E1A, a tumor suppressor gene. DC-Cholesterol is the only non-viral gene delivery system that has demonstrated to date, in two published human clinical studies, effective gene delivery and biological activity.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.